BPA Call 36E79720A0007-36C24120N0812
Award Date
7/21/20
Potential Completion Date
9/30/20
Potential Value
$30K
Federal Agency
Veterans Integrated Service Network 1
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chelsea, ME 04330, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Otsuka America Pharmaceutical Inc. has been awarded a $12,580.72 delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide tolvaptan. The order was issued against Otsuka's Federal Supply Schedule contract for Pharmaceuticals and Drugs under schedule number FSS-61-IB, with performance taking place in Potomac, Maryland. The contract type is firm fixed price and there is no set-aside designation. Otsuka holds two major...
This federal contract award is for the delivery of the pharmaceutical product TOLVAPTIN to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) facilities. The contract was awarded to the prime contractor Otsuka America Pharmaceutical Inc., a for-profit manufacturer and supplier of pharmaceuticals and drugs. The contract has a period of performance through September 30, 2022 and a potential value of $144,045.41. It was awarded on a firm-fixed price basis under the VA's...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $10,034.63 firm fixed price call against the Pharmaceuticals and Drugs Federal Supply Schedule to Otsuka America Pharmaceutical Inc. for the delivery of tolvaptan. Place of performance will be in Pittsburgh, Pennsylvania. The contract was awarded on April 1, 2020 with an anticipated completion date of April 10, 2020. No set-aside designation was used for this BPA call against GSA...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $297,067.94 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Otsuka America Pharmaceutical Inc. The firm fixed price order is for the provision of Tolvaptan (Jynarque), a medication for direct patient care, with performance at a location in Potomac, Maryland. Delivery is required by September 30, 2022. No set-aside designation was applied to this order...
This is a firm-fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The contract is for the bulk purchase of the medication Tolvaptan (Jynarque) to support VA healthcare programs and services for eligible veterans across the country. The contract has a potential value of $203,334.36 and a completion date of September 30, 2022. This...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Otsuka America Pharmaceutical Inc., a for-profit manufacturer of pharmaceuticals, for the supply of the drug TOLVAPTAN (JYNARQUE) for the treatment of kidney disorders. The $102,766.58 firm-fixed price order was issued under Otsuka's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), without any set-aside designations. Otsuka has held multiple VA delivery orders...
This federal contract award is to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier, to provide the drug Jynarque (tolvaptan) to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $73,251.35 firm-fixed price delivery order falls under Otsuka's $396 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which enables Otsuka to deliver medications to VA facilities nationwide through March...
This is a $12,580.72 firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, for the supply of the drug Jynarque (tolvaptan). The order is placed under Otsuka's $396 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which enables the efficient procurement of Otsuka's commercial drug products to support healthcare services and treatments...
This federal contract award to Otsuka America Pharmaceutical Inc. is a Delivery Order with a ceiling value of $362,719.21. The contract is issued under a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for Pharmaceuticals and Drugs (FSS-61-IB). The award is for the drug Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease and hyponatremia. Otsuka America Pharmaceutical is a for-profit pharmaceutical manufacturer that...
This federal contract award is for the delivery of the prescription drug Jynarque (tolvaptan) to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $50,332.88 firm-fixed price delivery order was awarded to Otsuka America Pharmaceutical Inc., a major pharmaceutical manufacturer and supplier. The contract is under Otsuka's $396 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which enables Otsuka to provide...